Chemoinformaics analysis of (4eta,5eta)-Aristol-1(10)-en-2-one
| Molecular Weight | 218.34 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
| Exact Molecular Weight | 218.167 | nRing | 3 |
| Solubility: LogS | -4.784 | nHRing | 0 |
| Solubility: LogP | 3.218 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.607 |
| Synth | 4.194 |
| Natural Product Likeliness | 3.065 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.989 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.757 |
| MDCK | 0.0000219 |
| BBB | 0.563 |
| PPB | 0.913079 |
| VDSS | 0.569 |
| FU | 0.0839371 |
| CYP1A2-inh | 0.098 |
| CYP1A2-sub | 0.555 |
| CYP2c19-inh | 0.584 |
| CYP2c19-sub | 0.938 |
| CYP2c9-inh | 0.381 |
| CYP2c9-sub | 0.818 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.727 |
| CYP3a4-inh | 0.079 |
| CYP3a4-sub | 0.543 |
| CL | 18.465 |
| T12 | 0.153 |
| hERG | 0.01 |
| Ames | 0.006 |
| ROA | 0.069 |
| SkinSen | 0.154 |
| Carcinogencity | 0.178 |
| EI | 0.069 |
| Respiratory | 0.922 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.870764 |